KSHV Viral Protein Kinase Interacts with USP9X to Modulate the Viral Lifecycle

J Virol. 2023 Mar 30;97(3):e0176322. doi: 10.1128/jvi.01763-22. Epub 2023 Mar 6.

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent of Kaposi sarcoma (KS), the plasmablastic form of multicentric Castleman's disease, and primary effusion lymphoma. In sub-Saharan Africa, KS is the most common HIV-related malignancy and one of the most common childhood cancers. Immunosuppressed patients, including HIV-infected patients, are more prone to KSHV-associated disease. KSHV encodes a viral protein kinase (vPK) that is expressed from ORF36. KSHV vPK contributes to the optimal production of infectious viral progeny and upregulation of protein synthesis. To elucidate the interactions of vPK with cellular proteins in KSHV-infected cells, we used a bottom-up proteomics approach and identified host protein ubiquitin-specific peptidase 9X-linked (USP9X) as a potential interactor of vPK. Subsequently, we validated this interaction using a co-immunoprecipitation assay. We report that both the ubiquitin-like and the catalytic domains of USP9X are important for association with vPK. To uncover the biological relevance of the USP9X/vPK interaction, we investigated whether the knockdown of USP9X would modulate viral reactivation. Our data suggest that depletion of USP9X inhibits both viral reactivation and the production of infectious virions. Understanding how USP9X influences the reactivation of KSHV will provide insights into how cellular deubiquitinases regulate viral kinase activity and how viruses co-opt cellular deubiquitinases to propagate infection. Hence, characterizing the roles of USP9X and vPK during KSHV infection constitutes a first step toward identifying a potentially critical interaction that could be targeted by future therapeutics. IMPORTANCE Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent of Kaposi sarcoma (KS), the plasmablastic form of multicentric Castleman's disease, and primary effusion lymphoma. In sub-Saharan Africa, KS is the most common HIV-related malignancy. KSHV encodes a viral protein kinase (vPK) that aids viral replication. To elucidate the interactions of vPK with cellular proteins in KSHV-infected cells, we used an affinity purification approach and identified host protein ubiquitin-specific peptidase 9X-linked (USP9X) as a potential interactor of vPK. Depletion of USP9X inhibits both viral reactivation and the production of infectious virions. Overall, our data suggest a proviral role for USP9X.

Keywords: KSHV; USP9X; gammaherpesvirus; viral protein kinase.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Castleman Disease
  • Child
  • Deubiquitinating Enzymes
  • HIV Infections / complications
  • Herpesvirus 8, Human* / physiology
  • Humans
  • Lymphoma, Primary Effusion
  • Protein Kinases / genetics
  • Protein Kinases / metabolism
  • Sarcoma, Kaposi* / metabolism
  • Sarcoma, Kaposi* / pathology
  • Sarcoma, Kaposi* / virology
  • Ubiquitin Thiolesterase* / genetics
  • Viral Proteins / genetics

Substances

  • Deubiquitinating Enzymes
  • Protein Kinases
  • Ubiquitin Thiolesterase
  • USP9X protein, human
  • Viral Proteins

Supplementary concepts

  • Multi-centric Castleman's Disease